| A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis CA Marra, JC Woolcott, JA Kopec, K Shojania, R Offer, JE Brazier, ... Social science & medicine 60 (7), 1571-1582, 2005 | 494 | 2005 |
| Dual energy computed tomography in tophaceous gout HK Choi, AM Al-Arfaj, A Eftekhari, PL Munk, K Shojania, G Reid, ... Annals of the rheumatic diseases 68 (10), 1609-1612, 2009 | 452 | 2009 |
| Psoriasis and pustular dermatitis triggered by TNF-α inhibitors in patients with rheumatologic conditions GC de Gannes, M Ghoreishi, J Pope, A Russell, D Bell, S Adams, ... Archives of Dermatology 143 (2), 223-231, 2007 | 403 | 2007 |
| Development and validation of the spondyloarthritis research consortium of Canada (SPARCC) enthesitis index WP Maksymowych, C Mallon, S Morrow, K Shojania, WP Olszynski, ... Annals of the rheumatic diseases 68 (6), 948-953, 2009 | 341 | 2009 |
| Dual energy CT in gout: a prospective validation study HK Choi, LC Burns, K Shojania, N Koenig, G Reid, M Abufayyah, G Law, ... Annals of the rheumatic diseases 71 (9), 1466-1471, 2012 | 266 | 2012 |
| Reliability of the knee examination in osteoarthritis: effect of standardization J Cibere, N Bellamy, A Thorne, JM Esdaile, KJ McGorm, A Chalmers, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 215 | 2004 |
| The rising prevalence and incidence of gout in British Columbia, Canada: population-based trends from 2000 to 2012 SK Rai, JA Aviña-Zubieta, N McCormick, MA De Vera, K Shojania, ... seminars in arthritis and rheumatism 46 (4), 451-456, 2017 | 151 | 2017 |
| Test of Memory Malingering (TOMM) scores are not affected by chronic pain or depression in patients with fibromyalgia GL Iverson, JL Page, BE Koehler, K Shojania, M Badii The Clinical Neuropsychologist 21 (3), 532-546, 2007 | 126 | 2007 |
| Efficacy, tolerability, and safety of cannabinoid treatments in the rheumatic diseases: a systematic review of randomized controlled trials MA Fitzcharles, PA Ste‐Marie, W Häuser, DJ Clauw, S Jamal, J Karsh, ... Arthritis care & research 68 (5), 681-688, 2016 | 119 | 2016 |
| Cardiovascular risk factor screening in systemic lupus erythematosus. A Al-Herz, S Ensworth, K Shojania, JM Esdaile The Journal of Rheumatology 30 (3), 493-496, 2003 | 111 | 2003 |
| Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review K Huang, O Vinik, K Shojania, J Yeung, R Shupak, M Nimmo, ... Rheumatology international 39 (11), 1971-1981, 2019 | 105 | 2019 |
| Infliximab treatment of rheumatoid arthritis and Crohn's disease IK Nahar, K Shojania, CA Marra, AH Alamgir, AH Anis Annals of Pharmacotherapy 37 (9), 1256-1265, 2003 | 104 | 2003 |
| CanVasc recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides L McGeoch, M Twilt, L Famorca, V Bakowsky, L Barra, SM Benseler, ... The Journal of Rheumatology 43 (1), 97-120, 2016 | 99 | 2016 |
| Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies SK Rai, HK Choi, SHJ Choi, AF Townsend, K Shojania, MA De Vera Rheumatology 57 (7), 1282-1292, 2018 | 98 | 2018 |
| Reliability of the hip examination in osteoarthritis: effect of standardization J Cibere, A Thorne, N Bellamy, N Greidanus, A Chalmers, N Mahomed, ... Arthritis Care & Research 59 (3), 373-381, 2008 | 97 | 2008 |
| An overview of economic evaluations for drugs used in rheumatoid arthritis: Focus on tumour necrosis factor-α antagonists NJ Bansback, DA Regier, R Ara, A Brennan, K Shojania, JM Esdaile, ... Drugs 65 (4), 473-496, 2005 | 96 | 2005 |
| Hypoglycemia induced by hydroxychloroquine in a type II diabetic treated for polyarthritis. K Shojania, BE Koehler, T Elliott The Journal of Rheumatology 26 (1), 195-196, 1999 | 83 | 1999 |
| Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints MA Fitzcharles, PA Ste-Marie, DJ Clauw, S Jamal, J Karsh, S LeClercq, ... BMC musculoskeletal disorders 15 (1), 258, 2014 | 78 | 2014 |
| Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis WP Maksymowych, P Rahman, K Shojania, WP Olszynski, GTD Thomson, ... The Journal of rheumatology 35 (10), 2030-2037, 2008 | 66 | 2008 |
| Do spouses know how much fatigue, pain, and physical limitation their partners with rheumatoid arthritis experience? Implications for social support AJ Lehman, DD Pratt, A DeLongis, JB Collins, K Shojania, B Koehler, ... Arthritis care & research 63 (1), 120-127, 2011 | 62 | 2011 |
Aslam H AnisSchool of Population and Public Health, University of British ColumbiaVerified email at ubc.ca
